根据最新一期财务数据，2025年1月-3月，振华股份实现营业收入10.198亿元，同比增加7.59%；归属净 利润1.174亿元，同比增加37.27%；扣非净利润1.149亿元，同比增加29.93%。 截至2025年3月，振华股份筹码集中度较集中。十大股东持股合计占比47.57%，十大流通股东持股合计 占比47.57%。股东人数1.859万户，人均流通股2.739万股，人均持股金额34.07万元。 可转换债券简称可转债，是一种可以在特定时间、按特定条件转换为普通股票的特殊企业债券，兼具债 权和股权的特征。一般而言，持有人可按照发行时约定的价格将债券转换成公司的普通股票的债券。如 果债券持有人不想转换，则可以继续持有债券，直到偿还期满时收取本金和利息，或者在流通市场出售 变现。 资料显示，湖北振华化学股份有限公司(股票代码SH.603067)是目前全球范围内最具规模的铬盐上市企 业,公司维生素K3的生产能力位居全球前列。公司是高新技术企业,分别在湖北黄石、重庆潼南设有生产 基地,拥有"民众"、"楚高"两大业内知名品牌,公司综合竞争力全球领先。公司主要产品有重铬酸钠、重 铬酸钾、铬酸酐、氧化铬绿、碱式硫酸铬、精制 ...

Company Overview - Hubei Zhenhua Chemical Co., Ltd. is currently the largest listed chromium salt company globally, with significant production capacity for Vitamin K3 [2] - The company operates high-tech enterprises with production bases in Huangshi, Hubei, and Tongnan, Chongqing, and owns well-known brands "Minzhong" and "Chugao" [2] - Zhenhua's main products include sodium dichromate, potassium dichromate, chromium trioxide, chromium oxide green, basic chromium sulfate, refined yellow powder, chromium yellow, metallic chromium, ultra-fine aluminum hydroxide, and Vitamin K3 [2] Financial Performance - For the period of January to March 2025, Zhenhua achieved a revenue of 1.0198 billion yuan, representing a year-on-year increase of 7.59% [2] - The net profit attributable to shareholders was 117.4 million yuan, reflecting a year-on-year increase of 37.27% [2] - The net profit after deducting non-recurring items was 114.9 million yuan, showing a year-on-year increase of 29.93% [2] Shareholder Structure - As of March 2025, the concentration of shares is relatively high, with the top ten shareholders holding a combined 47.57% of the shares [2] - The total number of shareholders is 18,590, with an average of 27,390 circulating shares per person and an average holding amount of 340,700 yuan [2] Convertible Bond Information - Zhenhua's convertible bond experienced a decline of 3.55%, trading at 198.886 yuan per bond, with a transaction volume of 104 million yuan and a conversion premium rate of 8.95% [1] - The convertible bond has a credit rating of "AA" and a maturity of 6 years, with a coupon rate that increases over the years, starting from 0.20% in the first year to 2.00% in the sixth year [1] - The conversion price for the bond is set at 8.2 yuan, with the conversion period starting on January 20, 2025 [1]

Group 1 - The company, Hubei Zhenhua Chemical Co., Ltd., has issued convertible bonds totaling RMB 406.21 million, with a maturity of 6 years and a face value of RMB 100 per bond [3][4][19] - The bonds were approved by the Shanghai Stock Exchange and the China Securities Regulatory Commission, with the first issuance date on August 2, 2024 [3][4] - The company reported a revenue of RMB 406,671.94 million for 2024, representing a year-on-year increase of 9.95%, and a net profit of RMB 47,287.64 million, up 27.53% from the previous year [19][20] Group 2 - The bonds have a tiered interest rate structure, starting at 0.20% in the first year and increasing to 2.00% in the sixth year [4][5] - The initial conversion price for the bonds is set at RMB 11.64 per share, with provisions for adjustments based on corporate actions such as stock dividends and capital increases [6][8] - The company has established a dedicated fund management system for the raised capital, ensuring compliance with regulatory requirements and protecting investor interests [20][21] Group 3 - The company’s total assets increased by 18.98% year-on-year, reaching RMB 505,580.73 million by the end of 2024 [20] - The company’s net assets attributable to shareholders rose by 12.59% to RMB 315,899.40 million [20] - The company is engaged in the production and sale of chromium chemicals and related products, including sodium dichromate and potassium dichromate [19]

Group 1 - Mianyang is focusing on attracting young talent to enhance its urban public services and create youth-friendly parks, with a significant increase in the number of skilled professionals moving to the city [6][7][8] - Over the past three years, Mianyang has attracted 86,000 talents, including over 15,000 master's and doctoral graduates, contributing to a projected increase of 11,000 permanent residents in 2024 [7][8] - The city aims to leverage its strengths in technology and industry to facilitate the transformation of new technologies into new industries, addressing the historical disconnect between research and industrial application [7][8] Group 2 - Mianyang has established a robust platform for innovation, with 28 signed projects in the nuclear medical health industry, totaling over 22.3 billion yuan in investment [7] - The magnetic materials industry in Mianyang is also developing, with companies like Juxing Permanent Magnet producing high-temperature resistant magnetic steel, expected to achieve a revenue of 2 billion yuan this year [7] - The Mianyang Technology City has launched a pilot service platform for rapid prototyping, which has attracted significant investment and interest from venture capital funds, indicating a growing ecosystem for startups [7][8] Group 3 - The city is implementing policies such as "bringing soil transplant" to encourage teams to carry their research achievements into entrepreneurship, retaining their original staffing for four years [7] - Mianyang's urban development has integrated youthful elements, transforming areas into vibrant cultural and recreational spaces, which has enhanced the city's appeal to young professionals [8] - The region's GDP growth has consistently ranked among the top three in the province over the past three years, reflecting the positive impact of innovation and talent influx [8]

2025 年第一季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 湖北振华化学股份有限公司 湖北振华化学股份有限公司（以下简称"公司"）根据上海证券交易所《上 市公司行业信息披露指引第十三号——化工》（2022 年修订）的要求，现将 2025 年第一季度主要经营数据披露如下： | 证券代码：603067 | 证券简称：振华股份 | 公告编号：2025-021 | | --- | --- | --- | | 债券代码：113687 | 债券简称：振华转债 | | 三、报告期内无其他对公司生产经营具有重大影响的事项。 四、其他说明 以上经营数据未经审计，为投资者及时了解公司生产经营情况之用，并未对 公司未来经营情况作出任何明示或默示的预测或保证，敬请投资者审慎使用。 特此公告。 一、主要产品的产量、销量及收入实现情况 | 主要产品 | 产量（万吨） | 销量（万吨） | 营业收入（万元） | | --- | --- | --- | --- | | 重铬酸盐 | 0.97 | 0.92 | 8,919.25 ...

| 证券代码:603067 | | --- | | 债券代码:113687 | | 主要产品 | 产量（万吨） | 销量（万吨） | 营业收入（万元） | | --- | --- | --- | --- | | 重铬酸盐 （重铬酸钠、重铬酸钾、铬黄） | 3.06 | 3.23 | 34,066.15 | | 铬的氧化物 （铬酸酐、铬绿） | 10.35 | 10.28 | 215,984.20 | | 铬盐联产产品 （维生素 K3、碱式硫酸铬） | 3.34 | 3.22 | 38,407.03 | | 超细氢氧化铝 | 3.96 | 4.08 | 15,369.47 | 二、主要产品和原材料的价格变动情况 （一）主要产品的价格变动情况（不含税） 证券代码：603067 证券简称：振华股份 公告编号：2025-020 债券代码：113687 债券简称：振华转债 湖北振华化学股份有限公司 2024 年年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 湖北振华化学股份有限公司（以下简称"公司"）根据上海 ...